Oryzon Genomics S.A. (ORYZF)
OTCMKTS
· Delayed Price · Currency is USD
3.030
0.00 (0.00%)
At close: May 7, 2025
Oryzon Genomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 7.95 | 7.62 | 15.69 | 16.78 | 12.07 | 11.65 | Upgrade
|
| Revenue Growth (YoY) | -48.05% | -51.43% | -6.50% | 38.97% | 3.65% | 0.98% | Upgrade
|
| Cost of Revenue | 0.33 | 0.31 | 0.27 | 0.5 | 0.85 | 0.64 | Upgrade
|
| Gross Profit | 7.63 | 7.31 | 15.42 | 16.28 | 11.22 | 11 | Upgrade
|
| Selling, General & Admin | 4.24 | 3.77 | 3.99 | 3.81 | 4.17 | 4.52 | Upgrade
|
| Other Operating Expenses | 8.4 | 8.05 | 16.31 | 18.16 | 14.86 | 11.56 | Upgrade
|
| Operating Expenses | 12.75 | 11.97 | 20.46 | 22.16 | 19.2 | 16.25 | Upgrade
|
| Operating Income | -5.12 | -4.66 | -5.04 | -5.87 | -7.98 | -5.25 | Upgrade
|
| Interest Expense | -1.44 | -1.27 | -2.09 | -1.2 | -0.52 | -0.57 | Upgrade
|
| Interest & Investment Income | 0.13 | 0.12 | 0.04 | 0.01 | 0.01 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.1 | -0.09 | 0.11 | 0.25 | 0.32 | -0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.17 | 0.05 | 0.23 | -0.21 | 0 | - | Upgrade
|
| EBT Excluding Unusual Items | -6.7 | -5.85 | -6.76 | -7.01 | -8.17 | -5.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0 | -0.01 | Upgrade
|
| Other Unusual Items | 0.09 | 0.08 | 0.02 | 0.01 | 0.01 | 0 | Upgrade
|
| Pretax Income | -6.62 | -5.77 | -6.75 | -7.01 | -8.17 | -5.85 | Upgrade
|
| Income Tax Expense | -2.06 | -1.97 | -3.04 | -2.48 | -2.84 | -1.69 | Upgrade
|
| Net Income | -4.56 | -3.79 | -3.71 | -4.52 | -5.33 | -4.16 | Upgrade
|
| Net Income to Common | -4.56 | -3.79 | -3.71 | -4.52 | -5.33 | -4.16 | Upgrade
|
| Shares Outstanding (Basic) | 65 | 65 | 61 | 55 | 53 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 65 | 65 | 61 | 55 | 53 | 53 | Upgrade
|
| Shares Change (YoY) | 5.77% | 6.35% | 10.10% | 4.80% | - | 15.99% | Upgrade
|
| EPS (Basic) | -0.07 | -0.06 | -0.06 | -0.08 | -0.10 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.07 | -0.06 | -0.06 | -0.08 | -0.10 | -0.08 | Upgrade
|
| Free Cash Flow | - | -5.89 | -0.64 | -2.06 | -4.32 | -6.08 | Upgrade
|
| Free Cash Flow Per Share | - | -0.09 | -0.01 | -0.04 | -0.08 | -0.12 | Upgrade
|
| Gross Margin | 95.89% | 95.89% | 98.28% | 97.04% | 92.97% | 94.47% | Upgrade
|
| Operating Margin | -64.40% | -61.18% | -32.16% | -35.02% | -66.07% | -45.06% | Upgrade
|
| Profit Margin | -57.32% | -49.81% | -23.63% | -26.96% | -44.15% | -35.70% | Upgrade
|
| Free Cash Flow Margin | - | -77.32% | -4.05% | -12.25% | -35.82% | -52.20% | Upgrade
|
| EBITDA | -4.99 | -4.53 | -4.9 | -5.72 | -7.82 | -5.09 | Upgrade
|
| EBITDA Margin | -62.70% | -59.47% | -31.24% | -34.08% | -64.81% | -43.67% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.13 | 0.14 | 0.16 | 0.15 | 0.16 | Upgrade
|
| EBIT | -5.12 | -4.66 | -5.04 | -5.87 | -7.98 | -5.25 | Upgrade
|
| EBIT Margin | -64.40% | -61.18% | -32.16% | -35.02% | -66.07% | -45.06% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.